Gregory T Kennedy
Overview
Explore the profile of Gregory T Kennedy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kennedy G, Azari F, Chang A, Bou-Samra P, Desphande C, Predina J, et al.
Mol Imaging Biol
. 2024 Jul;
26(4):585-592.
PMID: 38992245
Purpose: Intraoperative molecular imaging (IMI) uses tumor-targeted optical contrast agents to improve identification and clearance of cancer. Recently, a probe has been developed that only fluoresces when activated in an...
2.
Bou-Samra P, Kennedy G, Chang A, Guo E, Azari F, Din A, et al.
Ann Thorac Surg
. 2024 Jun;
119(3):625-633.
PMID: 38823756
Background: Advances in intraoperative molecular imaging (IMI) may improve surgical outcomes when resecting tumors in the lung. A single-center trial was conducted using VGT-309, a cathepsin-targeted near-infrared imaging agent that...
3.
Bou-Samra P, Chang A, Kelly N, Yudien M, Galandarova A, Ibrahimli A, et al.
Quant Imaging Med Surg
. 2023 Aug;
13(8):5447-5450.
PMID: 37581032
No abstract available.
4.
Azari F, Kennedy G, Chang A, Low P, Basil M, Planer J, et al.
Ann Thorac Surg
. 2023 Aug;
117(2):458-465.
PMID: 37572959
Background: Small animal models remain invaluable for the preclinical study of emerging molecular imaging agents. However, the data obtained in this setting are generated in genetically homogenous animals that do...
5.
Single-institution experience of 500 pulmonary resections guided by intraoperative molecular imaging
Kennedy G, Azari F, Chang A, Nadeem B, Bernstein E, Segil A, et al.
J Thorac Cardiovasc Surg
. 2023 Mar;
165(6):1928-1938.e1.
PMID: 36863974
Objective: Intraoperative molecular imaging (IMI) using tumor-targeted optical contrast agents can improve thoracic cancer resections. There are no large-scale studies to guide surgeons in patient selection or imaging agent choice....
6.
Azari F, Meijer R, Kennedy G, Hanna A, Chang A, Nadeem B, et al.
JAMA Netw Open
. 2023 Jan;
6(1):e2252885.
PMID: 36705924
Importance: Localization of subcentimeter ground glass opacities during minimally invasive thoracoscopic lung cancer resections is a significant challenge in thoracic oncology. Intraoperative molecular imaging has emerged as a potential solution,...
7.
Azari F, Kennedy G, Chang A, Nadeem B, Bou-Samra P, Chang A, et al.
Mol Imaging Biol
. 2022 Dec;
25(3):569-585.
PMID: 36534331
Background: Intraoperative molecular imaging (IMI)-guided resections have been shown to improve oncologic outcomes for patients undergoing surgery for solid malignancies. The technology utilizes fluorescent tracers targeting cancer cells without the...
8.
Singhal S, Azari F, Caponetti G, Kennedy G
J Cardiothorac Surg
. 2022 Dec;
17(1):302.
PMID: 36494869
Thoracic surgeons are frequently asked to biopsy suspicious tissues in the anterior mediastinum to discriminate between a reactive versus malignant pathology such as lymph nodes. The most common benign cause...
9.
Azari F, Kennedy G, Bou-Samra P, Singhal S
J Thorac Dis
. 2022 Nov;
14(10):3688-3691.
PMID: 36389330
No abstract available.
10.
Kennedy G, Azari F, Bernstein E, Marfatia I, Din A, Deshpande C, et al.
Transl Lung Cancer Res
. 2022 Sep;
11(8):1567-1577.
PMID: 36090642
Background: Identifying ground glass opacities (GGOs) is challenging during robot-assisted thoracic surgery (RATS). Intraoperative molecular imaging (IMI) using tumor-targeted fluorescent tracers may address this clinical problem, but has never been...